08/26/2026
We will be phasing out what is left of our Thorne stock. When its gone, its gone.
The multi-billion-dollar wellness landscape fractured overnight as Throne HealthTech, a long-revered bastion of clinical-grade purity, surrendered its independence to consumer goods titan Procter & Gamble (P&G) in a staggering $3.8 billion acquisition. For decades, practitioners and biohackers alike treated Thorne’s NSF-certified formulations as holy writ, trusting a brand that rigorously shunned the cheap fillers and synthetic shortcuts common in mass-market supplements. But as the ink dries on this massive corporate buyout, a shadow of skepticism looms over the brand’s pristine reputation. History has repeatedly demonstrated that when independent wellness pioneers are swallowed by mega-corporations, the relentless pressure for profit maximization inevitably collides with uncompromising quality.
This historic buyout serves as a critical warning for discerning consumers the time to scrutinize your ingredient labels is now. While P&G promises to scale Thorne’s clinical excellence, seasons wellness advocated known that corporate integration frequently triggers “formulation optimization”—a euphonium for replacing premium, bioavailable ingredients with cheaper, mass-produced alternatives to satisfy shareholders. To protect your health regimen, closely monitor the fine print on subsequent orders, looking for hidden changes in capsule composition, the introduction of artificial flowing agents, or subtle shifts in ingredient sourcing. In this new era of corporate-owned wellness, blind brand loyalty must be replaced by fierce vigilance, ensuring that the premium price you pay still commands the premium purity you deserve.
Check out the comments section for supplement brands that are still independently owned and clean if you feel like you do not want to financially support P&G (I have no affiliation with any of them). 🫶